Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2018.1542919
Abstract: ABSTRACT Background: Diabetes is a very common cause of cardiovascular disease, and metformin remains the first-line treatment of diabetes. Many trials were conducted to prove the efficacy and safety of other antidiabetic medication as the… read more here.
Keywords: effect incretin; randomized controlled; atherosclerotic effect; incretin mimetics ... See more keywords
Protective effect of incretin aganist age-related disease.
Sign Up to like & getrecommendations! Published in 2019 at "Current drug delivery"
DOI: 10.2174/1567201816666191010145029
Abstract: Incretin contains two peptides named glucagon-like peptide-1and glucose-dependent insulinotropic polypeptide. Incretin-based therapies have become a new class of antidiabetic drugs for its promising action on insulinotropic secretion and improving insulin receptor. Considering the fact which… read more here.
Keywords: effect incretin; related disease; age related; protective effect ... See more keywords